Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network

Christoph A. Ritter, Marianela Perez-Torres, Cammie Rinehart, Marta Guix, Teresa Dugger, Jeffrey A. Engelman, Carlos L. Arteaga

Research output: Contribution to journalArticlepeer-review

374 Scopus citations

Fingerprint Dive into the research topics of 'Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network'. Together they form a unique fingerprint.

Medicine & Life Sciences